arrow
H

Hok Pan Yuen

orygen, the national centre of excellence in youth mental health
H指数:52
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Differential effects of illness and antipsychotics on cortical thinning in first episode psychosis: A randomised placebo-controlled MRI study

精神疾病和抗精神病药物对首发精神病患者皮质变薄的差异性影响:一项随机安慰剂对照的MRI研究

2026-07-240
OA
Multimodal Approach to Preventing Suicide in Schools (MAPSS): a randomised controlled trial assessing the effectiveness, safety, and feasibility of an integrated response to suicide risk among secondary school students

学校预防自杀的多模式方法(MAPSS):一项评估针对中学生自杀风险的综合应对措施的有效性、安全性和可行性的随机对照试验

2026-04-170
PRE
Exploring the interconnections between baseline symptoms in ultra-high risk youth who did and did not transition to psychosis over three years: A network analysis comparison

探索超高危青少年基线症状之间的相互联系,这些青少年在三年内没有转变为精神病: 网络分析比较

2025-11-270
OAAI
Protocol update to a study protocol for the Multimodal Approach to Preventing Suicide in Schools (MAPSS) project: a regionally based randomised trial of an integrated response to suicide risk among secondary school students

对“学校多模式自杀预防方法”(MAPSS)项目研究方案进行的方案更新:一项基于区域层面的随机试验,旨在对中学学生中的自杀风险进行综合干预。

2025-09-240
OAAI
Therapy process factors in early psychosis: The effect of working alliance on clinical symptoms and cognitive biases in Ultra High Risk young people

早期精神病中的治疗过程因素:工作联盟对超高风险年轻人临床症状和认知偏差的影响

2025-08-060
OAAI
Predicting the First Onset of Suicidal Thoughts and Behaviors in Adolescents Using Multimodal Risk Factors: A Four-Year Longitudinal Study

使用多模态风险因素预测青少年首次出现自杀意念和行为:一项为期四年的纵向研究

2025-07-160
PRE
White Blood Cell Proportions Are Associated With Response to Psychosocial Therapy in Young People at Ultra-High Risk for Psychosis

白细胞比例与精神病超高风险青年对心理社会治疗的反应相关

2025-06-030
OAAI
New diagnosis in psychiatry: beyond heuristics

精神病学的新诊断: 超越启发式

2025-02-060
PRE
Brainwide Anatomical Connectivity and Prediction of Longitudinal Outcomes in Antipsychotic-Naïve First-Episode Psychosis
2025-01-012
PRE
Characterizing the Clinical Trajectory and Predicting Persistence and Deterioration of Attenuated Psychotic Symptoms in Ultra-High-Risk Individuals
2024-12-200
OA
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra-high risk in the UHR 1000+cohort

UHR 1000队列中超高危个体向精神病转变的临床预测模型的开发和时间验证

2024-09-160
OAAI
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
2024-09-060
PRE
Combining Clinical With Cognitive or Magnetic Resonance Imaging Data for Predicting Transition to Psychosis in Ultra High-Risk Patients: Data From the PACE 400 Cohort

将临床数据与认知或磁共振成像数据相结合,以预测超高风险患者向精神病的转变: 来自PACE 400队列的数据

2024-04-011
OAAI
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis

加速药物伙伴关系®精神分裂症 (AMP®SCZ): 最大的全球精神病临床高风险前瞻性队列研究的基本原理和研究设计

2024-03-0712
OAAI
The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial

在青少年抑郁症的认知行为案例管理中添加鱼油: 一项随机,双盲,安慰剂对照,多中心临床试验

2024-03-015
PRE
Effects of risperidone/paliperidone versus placebo on cognitive functioning over the first 6 months of treatment for psychotic disorder: secondary analysis of a triple-blind randomised clinical trial
2023-06-105
OAAI